UA40562C2 - 1,8-заміщені-2-амінотетралінові похідні або їх енантіомери і фізіологічно прийнятні солі та спосіб їх одержання (варіанти) - Google Patents

1,8-заміщені-2-амінотетралінові похідні або їх енантіомери і фізіологічно прийнятні солі та спосіб їх одержання (варіанти)

Info

Publication number
UA40562C2
UA40562C2 UA4894777A UA4894777A UA40562C2 UA 40562 C2 UA40562 C2 UA 40562C2 UA 4894777 A UA4894777 A UA 4894777A UA 4894777 A UA4894777 A UA 4894777A UA 40562 C2 UA40562 C2 UA 40562C2
Authority
UA
Ukraine
Prior art keywords
substituted
enantiomers
halogen
alkyl
hydrogen
Prior art date
Application number
UA4894777A
Other languages
English (en)
Russian (ru)
Inventor
Нільс-Ерік Анден
Нильс-Эрик Анден
Беріт Крістіна Елізабет Баклунд Хьок
Берит Кристина Элизабет Баклунд Хек
Анна Лена Марія Бьорк
Анна Лена Мария Берк
Улі Альф Хаксел
Ули Альф Хаксел
Свен Ерік Хілвер
Свен Эрик Хилвер
Йє Ліу
Йе ЛИУ
Ева Шарлотта Мелін
Эва Шарлотта Мелин
Єва Маріє Персон
Ева Марие Персон
Карл Ерк Валгарда
Карл Эрк Валгарда
Хонг Іу
Хонг Иу
Original Assignee
Астра Актієболаг
Астра АБ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астра Актієболаг, Астра АБ filed Critical Астра Актієболаг
Publication of UA40562C2 publication Critical patent/UA40562C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polyamides (AREA)

Abstract

Винахід належить до нових 8-карбоніларилзаміщених 2-амінотетралінів, їх енантіомерів і солей, способів їх отримання, лікарських препаратів на їхній основі і застосування зазначених сполук в терапії. 1,8-заміщені-2-амінотетралінові похідні загальної формули (I) де R - водень або метил за умови, що С1-метильний замісник знаходиться в ціс-конфігурації; Z - водень або галоген; Q - COR1 або феніл, фурил, тиєніл, піразоліл, тіазоліл, піриділ, хіноліл, індоксазиніл, індоліл, бензофураніл, необов’язково заміщений галогеном або нижчим алкоксі; R1 – С1-С6-алкіл або фенил, необов’язково заміщений галогеном або нижчим алкоксі, або С3-С6-циклоалкіл; R2 - водень або C1-C6-алкіл; R3 - група С1-С6-алкіл або -(CH2)a-R4, де а = 4, R4 - -NR11R12, R11 і R12 разом з атомом азоту утворюють кільце n = 1 або 2, або їхні енантіомери і фізіологічно прийнятні солі.
UA4894777A 1989-05-26 1990-05-23 1,8-заміщені-2-амінотетралінові похідні або їх енантіомери і фізіологічно прийнятні солі та спосіб їх одержання (варіанти) UA40562C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8901889A SE8901889D0 (sv) 1989-05-26 1989-05-26 Novel 8-substituted-2-aminotetralines
PCT/SE1990/000351 WO1990014330A1 (en) 1989-05-26 1990-05-23 Novel 8-substituted-2-aminotetralines

Publications (1)

Publication Number Publication Date
UA40562C2 true UA40562C2 (uk) 2001-08-15

Family

ID=20376074

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4894777A UA40562C2 (uk) 1989-05-26 1990-05-23 1,8-заміщені-2-амінотетралінові похідні або їх енантіомери і фізіологічно прийнятні солі та спосіб їх одержання (варіанти)

Country Status (41)

Country Link
US (1) US5635537A (uk)
EP (1) EP0399982B1 (uk)
JP (1) JP2818692B2 (uk)
KR (1) KR100193981B1 (uk)
CN (1) CN1023399C (uk)
AT (1) ATE129696T1 (uk)
AU (1) AU644081B2 (uk)
CA (1) CA2032498C (uk)
CY (1) CY1989A (uk)
CZ (1) CZ286038B6 (uk)
DD (1) DD298909A5 (uk)
DE (1) DE69023274T2 (uk)
DK (1) DK0399982T3 (uk)
DZ (1) DZ1417A1 (uk)
ES (1) ES2078962T3 (uk)
FI (1) FI114151B (uk)
GR (1) GR3018566T3 (uk)
HK (1) HK55697A (uk)
HR (1) HRP920622B1 (uk)
HU (2) HUT58685A (uk)
IE (1) IE75057B1 (uk)
IL (1) IL94428A (uk)
IS (1) IS1663B (uk)
JO (1) JO1617B1 (uk)
LT (1) LT3966B (uk)
LV (2) LV10243B (uk)
MX (1) MX20842A (uk)
NO (1) NO176603C (uk)
NZ (1) NZ233724A (uk)
PH (1) PH31110A (uk)
PL (2) PL164245B1 (uk)
PT (1) PT94163B (uk)
RU (1) RU2093507C1 (uk)
SA (1) SA90100274B1 (uk)
SE (1) SE8901889D0 (uk)
SI (1) SI9011006B (uk)
SK (1) SK280731B6 (uk)
UA (1) UA40562C2 (uk)
WO (1) WO1990014330A1 (uk)
YU (1) YU48830B (uk)
ZA (1) ZA903801B (uk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2785879B2 (ja) 1989-05-31 1998-08-13 ジ・アップジョン・カンパニー 治療学的に有用な２―アミノテトラリン誘導体
DK0471515T3 (da) * 1990-08-15 1997-07-21 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronphtalener, 3-aminochromaner og 3-aminothiochromaner
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
ES2153071T3 (es) * 1991-02-08 2001-02-16 Lilly Co Eli 2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en anillo.
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
US5656653A (en) * 1991-03-28 1997-08-12 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
AU1106195A (en) * 1994-11-09 1996-06-06 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
GB9509156D0 (en) * 1995-05-05 1995-06-28 Sandoz Ltd Organic compounds
ES2566479T3 (es) * 2006-01-06 2016-04-13 Sunovion Pharmaceuticals Inc. Inhibidores de reabsorción de monoamina con base en tetralona
AU2022238849A1 (en) 2021-03-17 2023-08-31 Receptos Llc Methods of treating atopic dermatitis with anti il-13 antibodies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4247907A (en) * 1978-11-27 1981-01-27 International Business Machines Corporation Method and apparatus for typing characters and optically readable binary representations thereof on same page
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
EP0168505B1 (en) * 1984-05-22 1989-08-09 Whitby Research Incorporated Substituted 2-aminotetralins and processes for synthesis
EP0209275B1 (en) * 1985-06-26 1988-10-19 Smithkline Beckman Corporation Benz-trisubstituted 2-aminotetralins
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
WO1990007490A1 (en) * 1989-01-09 1990-07-12 The Upjohn Company Halo substituted aminotetralins
JP2785879B2 (ja) * 1989-05-31 1998-08-13 ジ・アップジョン・カンパニー 治療学的に有用な２―アミノテトラリン誘導体

Also Published As

Publication number Publication date
IL94428A0 (en) 1991-03-10
ZA903801B (en) 1991-01-30
DZ1417A1 (fr) 2004-09-13
SI9011006A (en) 1997-12-31
DK0399982T3 (da) 1996-03-04
AU5818590A (en) 1990-12-18
IS1663B (is) 1997-07-04
CY1989A (en) 1997-09-05
CA2032498C (en) 2002-03-26
LV11736A (lv) 1997-04-20
HU904810D0 (en) 1991-06-28
RU2093507C1 (ru) 1997-10-20
CZ286038B6 (cs) 1999-12-15
PL285330A1 (en) 1991-11-04
KR920701121A (ko) 1992-08-11
LV10243A (lv) 1994-10-20
IE75057B1 (en) 1997-08-27
YU48830B (sh) 2002-03-18
GR3018566T3 (en) 1996-03-31
FI910381A0 (fi) 1991-01-25
JPH04500362A (ja) 1992-01-23
NO910310D0 (no) 1991-01-25
KR100193981B1 (ko) 1999-06-15
JO1617B1 (en) 1991-11-27
CZ256090A3 (cs) 1999-10-13
IL94428A (en) 1995-12-31
EP0399982B1 (en) 1995-11-02
SE8901889D0 (sv) 1989-05-26
PH31110A (en) 1998-02-23
SK256090A3 (en) 2000-07-11
WO1990014330A1 (en) 1990-11-29
LTIP1723A (en) 1995-08-25
DD298909A5 (de) 1992-03-19
HRP920622A2 (en) 1998-06-30
LT3966B (en) 1996-05-27
YU100690A (en) 1992-05-28
MX20842A (es) 1993-11-01
NZ233724A (en) 1993-01-27
SI9011006B (sl) 1998-12-31
HUT58685A (en) 1992-03-30
NO910310L (no) 1991-01-25
PT94163A (pt) 1991-01-08
PL164245B1 (pl) 1994-07-29
ATE129696T1 (de) 1995-11-15
FI114151B (fi) 2004-08-31
CN1047494A (zh) 1990-12-05
DE69023274D1 (de) 1995-12-07
EP0399982A1 (en) 1990-11-28
IE901833L (en) 1990-11-26
NO176603B (no) 1995-01-23
JP2818692B2 (ja) 1998-10-30
LV10243B (en) 1995-04-20
PT94163B (pt) 1996-12-31
LV11736B (en) 1997-10-20
CA2032498A1 (en) 1990-11-27
AU644081B2 (en) 1993-12-02
ES2078962T3 (es) 1996-01-01
PL165166B1 (pl) 1994-11-30
CN1023399C (zh) 1994-01-05
US5635537A (en) 1997-06-03
IS3580A7 (is) 1990-11-27
NO176603C (no) 1995-05-03
HU211880A9 (en) 1995-12-28
SK280731B6 (sk) 2000-07-11
SA90100274B1 (ar) 2005-06-01
DE69023274T2 (de) 1996-04-11
HRP920622B1 (en) 2000-04-30
HK55697A (en) 1997-05-09

Similar Documents

Publication Publication Date Title
UA40562C2 (uk) 1,8-заміщені-2-амінотетралінові похідні або їх енантіомери і фізіологічно прийнятні солі та спосіб їх одержання (варіанти)
PL278115A1 (en) The production method of tiazolidin-2,4-dion
NO961655L (no) Visse sammensmeltede pyrrolkarboksanilider; en ny klasse GABA-hjernereseptorligander
NO890074D0 (no) Fremgangsmaate for fremstilling av substituerte pyrrol-, pyrazol- og triazolderivater.
NZ528851A (en) N-aroyl cyclic amines
IS1682B (is) Aðferð til framleiðslu pyrrol afleiða og milliefni til notkunar við framleiðsluna
MY125295A (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
NO920614L (no) Forbindelse med antitumorvirkning og fremstilling derav
GB1424450A (en) Isoindoline intermediates
GB1382770A (en) Isoindoline derivatives
DE68928045T2 (de) Muscarinrezeptorantagonisten
MY141374A (en) Water soluble camptothecin derivatives
ES476011A1 (es) Procedimiento para preparar 1-halo-1-propin-3-oles.
FR2473522B1 (uk)
JPS51131870A (en) A process for preparing novel amide compounds
HK1034074A1 (en) 1,2-dihydro-2-oxoquinoline derivatives
HU902029D0 (en) Process for producing thio-formamide derivatives and pharmaceutical preparatives containing these compounds
FI912382A0 (fi) Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi
EP0116255A3 (en) Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives
DK492687A (da) Indolquinoxaliner med substituenter i 6-stilling indeholdende cykliske grupper
ATE91077T1 (de) Verwendung von cinnamamid-derivaten zur entspannung der muskeln.
GB2009155A (en) Pyridine Derivatives
IT1250411B (it) Oligopeptidi eterociclici dotati di attivita' antitumorale
JPS52128368A (en) Novel carboxylic acid amide derivatives and their preparation
HU9301770D0 (en) Method for producing [pure[ derivatives of propionamide